Export leadership Helena Laboratories has a strong track record in exports, evidenced by the U.S. Secretary of Commerce E Award. This suggests established international distribution channels and credibility that can be leveraged to expand global instrument and reagent sales to hospitals and laboratories abroad.

Global expansion Recent international activity includes opening a location in the United Kingdom and Northern Europe, indicating a growth-oriented strategy and readiness to support European customers with localized service, spare parts, and training.

Product leadership With hundreds of laboratory products and over 40 registered patents, Helena positions itself as an innovator in diagnostics. This creates opportunities for upselling advanced reagents and state-of-the-art analytical instruments to research centers and large clinical laboratories seeking cutting-edge solutions.

Mid-market focus Company revenue is in the $25M-$50M range with 51-200 employees, placing Helena in the mid-market segment where targeted account-based selling to major medical centers and reference laboratories could yield high-value contracts for instruments, consumables, and support packages.

Strategic partnerships A diverse client base across major medical centers, small hospitals, and private labs suggests potential for multi-year service agreements, maintenance contracts, and bundled reagent-instrument offerings that improve lifecycle value for customers and stabilize revenue.